Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.62 |
| ▸ | TSHR | P16473 | 2/20 | 0.62 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.62 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.62 |
| ▸ | CES2 | O00748 | 2/20 | 0.50 |
| ▸ | BCHE | P06276 | 2/20 | 0.50 |
| ▸ | ACHE | P22303 | 2/20 | 0.50 |
| ▸ | CES1 | P23141 | 2/20 | 0.50 |
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | RECQL | P46063 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | TP53 | P04637 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | HPGD | P15428 | 1/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.50 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL165983 | 0.78 | ALDH1A1 (1.00) | ALDH1A1TSHRHIF1ATDP1MEN1 | |
| SCHEMBL11703073 | 0.75 | CES2 (0.44) | ALDH1A1TSHRHIF1ATDP1CES2 | |
| Hydrochloric Acid SCHEMBL10715580 | 0.74 | ALDH1A1 (0.92) | ALDH1A1TSHRHIF1ATDP1MEN1 | |
| SCHEMBL9720387 | 0.74 | ALDH1A1 (0.92) | ALDH1A1TSHRHIF1ATDP1MEN1 | |
| SCHEMBL7620046 | 0.73 | — | — | |
| SCHEMBL11703608 | 0.71 | CES2 (0.47) | ALDH1A1TSHRHIF1ATDP1CES2 | |
| Cyclooctane SCHEMBL3271413 | 0.69 | ALDH1A1 (0.79) | ALDH1A1TSHRHIF1ATDP1MEN1 | |
| SCHEMBL2637337 | 0.69 | ALDH1A1 (0.56) | ALDH1A1TSHRHIF1ATDP1CES2 | |
| Chloranil SCHEMBL4682884 | 0.69 | CES2 (1.00) | ALDH1A1TSHRHIF1ATDP1CES2 | |
| Chloranil SCHEMBL24049 | 0.69 | CES2 (1.00) | ALDH1A1TSHRHIF1ATDP1CES2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 67 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117777051-B | Synthesis method of 2-bromo-5-chlorothiazole-4-carboxylate | 山西永津集团有限公司 | 2024-07-02 | — | — | CN | claimed |
| CN-117777051-A | Synthesis method of 2-bromo-5-chlorothiazole-4-carboxylate | 山西永津集团有限公司 | 2024-03-29 | — | — | CN | claimed |
| CN-117624261-A | Preparation method of sucralose-6-ethyl ester | 万华化学集团股份有限公司 | 2024-03-01 | — | — | CN | claimed |
| WO-2022040799-A1 | ANTIMICROBIAL COMPOSITION | GP TECH INOVASYON TEKNOLOJI VE ARASTIRMA A.S (TR) | 2022-03-03 | — | — | WO | claimed |
| US-20260060822-A1 | BIOENGINEERED SCAFFOLDS FOR VASCULAR GRAFTS AND METHODS OF USE THEREOF | UNIV WAKE FOREST HEALTH SCIENCES (US) | 2026-03-05 | — | — | US | disclosed |
| US-20260014091-A1 | COMPOSITIONS AND METHODS OF MAKING AND USE THEREOF | OHIO STATE INNOVATION FOUNDATION (US) | 2026-01-15 | — | — | US | disclosed |
| US-20250366978-A1 | DEVICES AND METHODS OF MAKING AND USE THEREOF | METHODIST HOSPITAL (US) | 2025-12-04 | — | — | US | disclosed |
| US-20250366979-A1 | DEVICES AND METHODS OF MAKING AND USE THEREOF | METHODIST HOSPITAL (US) | 2025-12-04 | — | — | US | disclosed |
| WO-2025128952-A1 | MANGANESE DOPED METAL ORGANIC FRAMEWORKS AND METHODS OF MAKING AND USE THEREOF | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2025-06-19 | — | — | WO | disclosed |
| WO-2025128946-A1 | DEVICES AND METHODS OF MAKING AND USE THEREOF | THE METHODIST HOSPITAL (US) | 2025-06-19 | — | — | WO | disclosed |
| US-20250135007-A1 | COMPOSITIONS COMPRISING STEROL-AMINO-PHOSPHATE COMPOUNDS AND METHODS OF MAKING AND USE THEREOF | OHIO STATE INNOVATION FOUNDATION | 2025-05-01 | — | — | US | disclosed |
| EP-4536139-A1 | DEVICES AND METHODS OF MAKING AND USE THEREOF | The Methodist Hospital (US) | 2025-04-16 | — | — | EP | disclosed |
| EP-1478613-A2 | SUBSTITUTED 10-ARYL-11H-BENZO[B]FLUORENES AND 7-ARYL-5,6-DIHYDRO-BENZ[A]ANTHRACENES FOR SELECTIVE EFFECTS ON ESTROGEN RECEPTORS | Akzo Nobel N.V. (NL) | 2004-11-24 | — | — | EP | disclosed |
| US-6756375-B2 | ESTROGEN RECEPTOR MODULATION; HORMONE REPLACEMENT THERAPY | AKZO NOBEL N.V. (NL) | 2004-06-29 | — | — | US | disclosed |
| US-20040059004-A1 | 10-ARYL-11H-BENZO[B]FLUORENE DERIVATIVES AND ANALOGS FOR MEDICINAL USE | MERCK SHARP & DOHME B.V. (NL) | 2004-03-25 | — | — | US | disclosed |
| WO-2003070675-A2 | SUBSTITUTED 10-ARYL-11H-BENZO[B]FLUORENES AND 7-ARYL-5,6-DIHYDRO-BENZO[A]ANTHRACENES FOR SELECTIVE EFFECTS ON ESTROGEN RECEPTORS | AKZO NOBEL N.V. (NL) | 2003-08-28 | — | — | WO | disclosed |
| EP-1313700-A1 | 10-ARYL-11H-BENZO[B]FLUORENE DERIVATIVES AND ANALOGS AS ESTROGENIC COMPOUNDS | Akzo Nobel N.V. (NL) | 2003-05-28 | — | — | EP | disclosed |
| WO-2002016316-A1 | 10-ARYL-11-HBENZO [b]FLUORENE DERIVATIVES AND ANALOGS FOR MEDICINAL USE | AKZO NOBEL N.V. (NL) | 2002-02-28 | — | — | WO | disclosed |
| US-4853153-A | USING REDUCING AGENT AND CHLORINATED CYCLIC KETONE | RHONE-POULENC CHIMIE (FR) | 1989-08-01 | — | — | US | disclosed |
| US-4822922-A | WITH PROTONIC AND/OR LEWIS ACID | RHONE-POULENC CHIMIE (FR) | 1989-04-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260014091-A1 | COMPOSITIONS AND METHODS OF MAKING AND USE THEREOF | ERBB3, ERBB2, EGFR | ALDH1A1 1799/4885TSHR 1318/4885HIF1A 3123/4885 |
| US-20250135007-A1 | COMPOSITIONS COMPRISING STEROL-AMINO-PHOSPHATE COMPOUNDS AND METHODS OF MAKING AND USE THEREOF | NASP, CYP27A1, CYP11A1 | ALDH1A1 3192/4885TSHR 4544/4885HIF1A 4107/4885 |
| US-20260060822-A1 | BIOENGINEERED SCAFFOLDS FOR VASCULAR GRAFTS AND METHODS OF USE THEREOF | PFKP, PBK, MYLK | ALDH1A1 1246/4885TSHR 4493/4885HIF1A 1457/4885 |
| US-20040059004-A1 | 10-ARYL-11H-BENZO[B]FLUORENE DERIVATIVES AND ANALOGS FOR MEDICINAL USE | ESRRA, ESR2, ESRRB | ALDH1A1 1045/4885TSHR 102/4885HIF1A 1234/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.